目的观察卡托普利治疗小儿血管迷走性晕厥(VS)的疗效并探讨其机制。
Objective to investigate the therapeutic effects of oral captopril on pediatric vasovagal syncope (VS) and its mechanism.
因为血管迷走神经性晕厥的特殊生理机制尚未明了,因此,很难鉴别可能存在血管迷走神经性晕厥的患者。
As specific physiologic triggers have not been clearly identified, it is difficult to identify those patients who may be at risk for vasovagal syncope.
因为血管迷走神经性晕厥的特殊生理机制尚未明了,因此,很难鉴别可能存在血管迷走神经性晕厥的患者。
As specific physiologic triggers have not been clearly identified, it is difficult to identify those patients who may be at risk for vasovagal syncope.
应用推荐